Gold nanoparticles have been used as a micro-CT contrast agent for the targeting of multiple tumor markers in mice, including Her2[14], the gastrin-releasing peptide (GRP) receptor[15], the folic acid receptor (FAR)[16], the LDL receptor [17], and tumor microcalcifications[18]. This evidence concerns the gene ERBB2 and neoplasm.